Randomized phase II trial of LV5FU2, LV5FU2-cisplatinum or LV5FU2-irinotecan in patients (pts) with metastatic gastric or cardial adenocarcinoma (MGA): Final results of study FFCD 9803. - Bouche,O.; Raoul,J.L.; Giovanini,M. (Proc Am Soc Clin Oncol, 2003)